12:00 AM
Jan 14, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aggrastat tirofiban regulatory update

Medicure submitted an sNDA to FDA to expand the label of Aggrastat tirofiban to include a high-dose regimen consisting of an initial bolus of 25 µg/kg Aggrastat and then continued at 0.15 µg/kg/min. The non-peptide Integrin...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >